 | • レポートコード：MRC2312MG09685 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、71ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界の放射性医薬品インジェクター市場規模と予測を収録しています。・世界の放射性医薬品インジェクター市場：売上、2018年-2023年、2024年-2029年 ・世界の放射性医薬品インジェクター市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の放射性医薬品インジェクター市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「PET放射性薬剤注入装置」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 放射性医薬品インジェクターのグローバル主要企業は、Medrad, Inc.(Bayer)、 UNIVERSAL GIKEN、 Comecer、 Sumitomo Heavy Industries、 Tema Sinergie、 Lemer Pax、 BQSVなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、放射性医薬品インジェクターのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の放射性医薬品インジェクター市場：タイプ別、2018年-2023年、2024年-2029年 世界の放射性医薬品インジェクター市場：タイプ別市場シェア、2022年 ・PET放射性薬剤注入装置、PET＆SPECT放射性薬剤注入装置 世界の放射性医薬品インジェクター市場：用途別、2018年-2023年、2024年-2029年 世界の放射性医薬品インジェクター市場：用途別市場シェア、2022年 ・病院＆診療所、研究開発機関 世界の放射性医薬品インジェクター市場：地域・国別、2018年-2023年、2024年-2029年 世界の放射性医薬品インジェクター市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における放射性医薬品インジェクターのグローバル売上、2018年-2023年 ・主要企業における放射性医薬品インジェクターのグローバル売上シェア、2022年 ・主要企業における放射性医薬品インジェクターのグローバル販売量、2018年-2023年 ・主要企業における放射性医薬品インジェクターのグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Medrad, Inc.(Bayer)、 UNIVERSAL GIKEN、 Comecer、 Sumitomo Heavy Industries、 Tema Sinergie、 Lemer Pax、 BQSV ************************************************************* ・調査・分析レポートの概要 放射性医薬品インジェクター市場の定義 市場セグメント 世界の放射性医薬品インジェクター市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の放射性医薬品インジェクター市場規模 世界の放射性医薬品インジェクター市場規模：2022年 VS 2029年 世界の放射性医薬品インジェクター市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの放射性医薬品インジェクターの売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の放射性医薬品インジェクター製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：PET放射性薬剤注入装置、PET＆SPECT放射性薬剤注入装置 放射性医薬品インジェクターのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院＆診療所、研究開発機関 放射性医薬品インジェクターの用途別グローバル売上・予測 ・地域別市場分析 地域別放射性医薬品インジェクター市場規模 2022年と2029年 地域別放射性医薬品インジェクター売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Medrad, Inc.(Bayer)、 UNIVERSAL GIKEN、 Comecer、 Sumitomo Heavy Industries、 Tema Sinergie、 Lemer Pax、 BQSV ... |
This research report provides a comprehensive analysis of the Radiopharmaceutical Injector market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Radiopharmaceutical Injector market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Radiopharmaceutical Injector, challenges faced by the industry, and potential opportunities for market players.
The global Radiopharmaceutical Injector market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Radiopharmaceutical Injector market presents opportunities for various stakeholders, including Hospitals and Clinics, R&D Institution. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Radiopharmaceutical Injector market. Additionally, the growing consumer demand present avenues for market expansion.
The global Radiopharmaceutical Injector market was valued at US$ 25 million in 2022 and is projected to reach US$ 44 million by 2029, at a CAGR of 7.8% during the forecast period.
Global key players of Radiopharmaceutical Injector include Medrad, Inc.(Bayer), UNIVERSAL GIKEN and Comecer, etc. The top three players hold a share over 65%. Medrad, Inc.(Bayer) is the largest manufacturers of Radiopharmaceutical Injector in the world, has a share about 30%. Europe is the largest market, has a share about 35%. In terms of product type, PET Radioactive Drugs Injector is the largest segment, occupied for a share of 85%, and in terms of application, Hospitals and Clinics has a share about 80 percent.
Key Features:
The research report on the Radiopharmaceutical Injector market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Radiopharmaceutical Injector market.
Market Overview: The report provides a comprehensive overview of the Radiopharmaceutical Injector market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., PET Radioactive Drugs Injector, PET and SPECT Radioactive Drugs Injector), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Radiopharmaceutical Injector market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Radiopharmaceutical Injector market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Radiopharmaceutical Injector market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Radiopharmaceutical Injector market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Radiopharmaceutical Injector market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Radiopharmaceutical Injector market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Radiopharmaceutical Injector, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Radiopharmaceutical Injector market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Radiopharmaceutical Injector market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
PET Radioactive Drugs Injector
PET and SPECT Radioactive Drugs Injector
Market segment by Application
Hospitals and Clinics
R&D Institution
Global Radiopharmaceutical Injector Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Medrad, Inc.(Bayer)
UNIVERSAL GIKEN
Comecer
Sumitomo Heavy Industries
Tema Sinergie
Lemer Pax
BQSV
Outline of Major Chapters:
Chapter 1: Introduces the definition of Radiopharmaceutical Injector, market overview.
Chapter 2: Global Radiopharmaceutical Injector market size in revenue and volume.
Chapter 3: Detailed analysis of Radiopharmaceutical Injector manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Radiopharmaceutical Injector in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Radiopharmaceutical Injector capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Radiopharmaceutical Injector Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Radiopharmaceutical Injector Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Radiopharmaceutical Injector Overall Market Size
2.1 Global Radiopharmaceutical Injector Market Size: 2022 VS 2029
2.2 Global Radiopharmaceutical Injector Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Radiopharmaceutical Injector Sales: 2018-2029
3 Company Landscape
3.1 Top Radiopharmaceutical Injector Players in Global Market
3.2 Top Global Radiopharmaceutical Injector Companies Ranked by Revenue
3.3 Global Radiopharmaceutical Injector Revenue by Companies
3.4 Global Radiopharmaceutical Injector Sales by Companies
3.5 Global Radiopharmaceutical Injector Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Radiopharmaceutical Injector Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Radiopharmaceutical Injector Product Type
3.8 Tier 1, Tier 2 and Tier 3 Radiopharmaceutical Injector Players in Global Market
3.8.1 List of Global Tier 1 Radiopharmaceutical Injector Companies
3.8.2 List of Global Tier 2 and Tier 3 Radiopharmaceutical Injector Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Radiopharmaceutical Injector Market Size Markets, 2022 & 2029
4.1.2 PET Radioactive Drugs Injector
4.1.3 PET and SPECT Radioactive Drugs Injector
4.2 By Type – Global Radiopharmaceutical Injector Revenue & Forecasts
4.2.1 By Type – Global Radiopharmaceutical Injector Revenue, 2018-2023
4.2.2 By Type – Global Radiopharmaceutical Injector Revenue, 2024-2029
4.2.3 By Type – Global Radiopharmaceutical Injector Revenue Market Share, 2018-2029
4.3 By Type – Global Radiopharmaceutical Injector Sales & Forecasts
4.3.1 By Type – Global Radiopharmaceutical Injector Sales, 2018-2023
4.3.2 By Type – Global Radiopharmaceutical Injector Sales, 2024-2029
4.3.3 By Type – Global Radiopharmaceutical Injector Sales Market Share, 2018-2029
4.4 By Type – Global Radiopharmaceutical Injector Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Radiopharmaceutical Injector Market Size, 2022 & 2029
5.1.2 Hospitals and Clinics
5.1.3 R&D Institution
5.2 By Application – Global Radiopharmaceutical Injector Revenue & Forecasts
5.2.1 By Application – Global Radiopharmaceutical Injector Revenue, 2018-2023
5.2.2 By Application – Global Radiopharmaceutical Injector Revenue, 2024-2029
5.2.3 By Application – Global Radiopharmaceutical Injector Revenue Market Share, 2018-2029
5.3 By Application – Global Radiopharmaceutical Injector Sales & Forecasts
5.3.1 By Application – Global Radiopharmaceutical Injector Sales, 2018-2023
5.3.2 By Application – Global Radiopharmaceutical Injector Sales, 2024-2029
5.3.3 By Application – Global Radiopharmaceutical Injector Sales Market Share, 2018-2029
5.4 By Application – Global Radiopharmaceutical Injector Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Radiopharmaceutical Injector Market Size, 2022 & 2029
6.2 By Region – Global Radiopharmaceutical Injector Revenue & Forecasts
6.2.1 By Region – Global Radiopharmaceutical Injector Revenue, 2018-2023
6.2.2 By Region – Global Radiopharmaceutical Injector Revenue, 2024-2029
6.2.3 By Region – Global Radiopharmaceutical Injector Revenue Market Share, 2018-2029
6.3 By Region – Global Radiopharmaceutical Injector Sales & Forecasts
6.3.1 By Region – Global Radiopharmaceutical Injector Sales, 2018-2023
6.3.2 By Region – Global Radiopharmaceutical Injector Sales, 2024-2029
6.3.3 By Region – Global Radiopharmaceutical Injector Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Radiopharmaceutical Injector Revenue, 2018-2029
6.4.2 By Country – North America Radiopharmaceutical Injector Sales, 2018-2029
6.4.3 US Radiopharmaceutical Injector Market Size, 2018-2029
6.4.4 Canada Radiopharmaceutical Injector Market Size, 2018-2029
6.4.5 Mexico Radiopharmaceutical Injector Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Radiopharmaceutical Injector Revenue, 2018-2029
6.5.2 By Country – Europe Radiopharmaceutical Injector Sales, 2018-2029
6.5.3 Germany Radiopharmaceutical Injector Market Size, 2018-2029
6.5.4 France Radiopharmaceutical Injector Market Size, 2018-2029
6.5.5 U.K. Radiopharmaceutical Injector Market Size, 2018-2029
6.5.6 Italy Radiopharmaceutical Injector Market Size, 2018-2029
6.5.7 Russia Radiopharmaceutical Injector Market Size, 2018-2029
6.5.8 Nordic Countries Radiopharmaceutical Injector Market Size, 2018-2029
6.5.9 Benelux Radiopharmaceutical Injector Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Radiopharmaceutical Injector Revenue, 2018-2029
6.6.2 By Region – Asia Radiopharmaceutical Injector Sales, 2018-2029
6.6.3 China Radiopharmaceutical Injector Market Size, 2018-2029
6.6.4 Japan Radiopharmaceutical Injector Market Size, 2018-2029
6.6.5 South Korea Radiopharmaceutical Injector Market Size, 2018-2029
6.6.6 Southeast Asia Radiopharmaceutical Injector Market Size, 2018-2029
6.6.7 India Radiopharmaceutical Injector Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Radiopharmaceutical Injector Revenue, 2018-2029
6.7.2 By Country – South America Radiopharmaceutical Injector Sales, 2018-2029
6.7.3 Brazil Radiopharmaceutical Injector Market Size, 2018-2029
6.7.4 Argentina Radiopharmaceutical Injector Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Radiopharmaceutical Injector Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Radiopharmaceutical Injector Sales, 2018-2029
6.8.3 Turkey Radiopharmaceutical Injector Market Size, 2018-2029
6.8.4 Israel Radiopharmaceutical Injector Market Size, 2018-2029
6.8.5 Saudi Arabia Radiopharmaceutical Injector Market Size, 2018-2029
6.8.6 UAE Radiopharmaceutical Injector Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Medrad, Inc.(Bayer)
7.1.1 Medrad, Inc.(Bayer) Company Summary
7.1.2 Medrad, Inc.(Bayer) Business Overview
7.1.3 Medrad, Inc.(Bayer) Radiopharmaceutical Injector Major Product Offerings
7.1.4 Medrad, Inc.(Bayer) Radiopharmaceutical Injector Sales and Revenue in Global (2018-2023)
7.1.5 Medrad, Inc.(Bayer) Key News & Latest Developments
7.2 UNIVERSAL GIKEN
7.2.1 UNIVERSAL GIKEN Company Summary
7.2.2 UNIVERSAL GIKEN Business Overview
7.2.3 UNIVERSAL GIKEN Radiopharmaceutical Injector Major Product Offerings
7.2.4 UNIVERSAL GIKEN Radiopharmaceutical Injector Sales and Revenue in Global (2018-2023)
7.2.5 UNIVERSAL GIKEN Key News & Latest Developments
7.3 Comecer
7.3.1 Comecer Company Summary
7.3.2 Comecer Business Overview
7.3.3 Comecer Radiopharmaceutical Injector Major Product Offerings
7.3.4 Comecer Radiopharmaceutical Injector Sales and Revenue in Global (2018-2023)
7.3.5 Comecer Key News & Latest Developments
7.4 Sumitomo Heavy Industries
7.4.1 Sumitomo Heavy Industries Company Summary
7.4.2 Sumitomo Heavy Industries Business Overview
7.4.3 Sumitomo Heavy Industries Radiopharmaceutical Injector Major Product Offerings
7.4.4 Sumitomo Heavy Industries Radiopharmaceutical Injector Sales and Revenue in Global (2018-2023)
7.4.5 Sumitomo Heavy Industries Key News & Latest Developments
7.5 Tema Sinergie
7.5.1 Tema Sinergie Company Summary
7.5.2 Tema Sinergie Business Overview
7.5.3 Tema Sinergie Radiopharmaceutical Injector Major Product Offerings
7.5.4 Tema Sinergie Radiopharmaceutical Injector Sales and Revenue in Global (2018-2023)
7.5.5 Tema Sinergie Key News & Latest Developments
7.6 Lemer Pax
7.6.1 Lemer Pax Company Summary
7.6.2 Lemer Pax Business Overview
7.6.3 Lemer Pax Radiopharmaceutical Injector Major Product Offerings
7.6.4 Lemer Pax Radiopharmaceutical Injector Sales and Revenue in Global (2018-2023)
7.6.5 Lemer Pax Key News & Latest Developments
7.7 BQSV
7.7.1 BQSV Company Summary
7.7.2 BQSV Business Overview
7.7.3 BQSV Radiopharmaceutical Injector Major Product Offerings
7.7.4 BQSV Radiopharmaceutical Injector Sales and Revenue in Global (2018-2023)
7.7.5 BQSV Key News & Latest Developments
8 Global Radiopharmaceutical Injector Production Capacity, Analysis
8.1 Global Radiopharmaceutical Injector Production Capacity, 2018-2029
8.2 Radiopharmaceutical Injector Production Capacity of Key Manufacturers in Global Market
8.3 Global Radiopharmaceutical Injector Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Radiopharmaceutical Injector Supply Chain Analysis
10.1 Radiopharmaceutical Injector Industry Value Chain
10.2 Radiopharmaceutical Injector Upstream Market
10.3 Radiopharmaceutical Injector Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Radiopharmaceutical Injector Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer